About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Alzheimer's Disease Clinical Trials in Phoenix | 240 Studies

Clinical Trials Alzheimer's DiseasePhoenix

Alzheimer's Disease Clinical Trials in Phoenix

Find 240 clinical trials for alzheimer's disease near Phoenix, Arizona. Connect with research centers in your area.

All Alzheimer's Disease trials nationwide All trials in Phoenix

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 201-220 of 240 trials

TerminatedOpen-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate AlzheimersThis is a Phase III, multicenter, open-label extension, single-group study in male and female outpatients with mild-to-moderate Alzheimer's disease (AD) who have completed either…NCT00490568·Litchfield Park, Arizona and 271 others

Alzheimer's Disease Trials in Other Cities

New York Los Angeles Chicago Houston Philadelphia San Antonio

Data from ClinicalTrials.govTerms

Recruiting[18F]PI-2620 Phase 3 Histopathological StudyThis study is an open-label, multi-center, non-randomized pivotal Phase 3 study to assess the efficacy and safety of PET imaging with \[18F\]PI-2620 for detection of tau…NCT05641688·Phoenix, Arizona and 24 others

TerminatedA Study to Evaluate the Safety, Tolerability, and Efficacy of Long-Term Gantenerumab Administration in Participants With Alzheimer's Disease (AD)This is an open-label, multicenter, rollover study to evaluate the safety, tolerability, and efficacy of long-term administration of open-label gantenerumab in participants with…NCT04374253·Phoenix, Arizona and 267 others

CompletedAlzheimer's Disease Neuroimaging Initiative Grand OpportunityThe purpose of this study is to build upon the information obtained in the original Alzheimer's Disease Neuroimaging Initiative (ADNI1), to examine how brain imaging technology…NCT01078636·Birmingham, Alabama and 54 others

Active not recruitingPhase 3, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AR1001 in Participants With Early Alzheimer's Disease (Polaris-AD)This AR1001-ADP3-US01 protocol is a double-blind, randomized, placebo-controlled, multi- center, parallel-group comparison pivotal Phase 3 study to evaluate the efficacy and…NCT05531526·Phoenix, Arizona and 197 others

Active not recruitingA Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)The purpose of this study is to measure the difference in time to developing or worsening memory, thinking, or functional problems due to Alzheimer's disease occurring in…NCT06653153·Birmingham, Alabama and 261 others

CompletedRegistry of Amyloid Positive Patients for Alzheimer's Disease Drug Research TrialsThis registry will be used to identify patients who have etiology diagnosed or suspected to be Alzheimer's disease and positive amyloid scans, and have indicated their interest in…NCT02918539·Glendale, Arizona and 74 others

CompletedSGS742 in Patients With Mild to Moderate Alzheimer's Disease (AD)The purpose of this trial is to determine the effect of a new drug, SGS742, on memory and cognition in patients with mild to moderate Alzheimer's disease.NCT00093951·Phoenix, Arizona and 58 others

CompletedAlzheimer's Disease Neuroimaging Initiative 2The purpose of this study is to build upon the information obtained in the original Alzheimer's Disease Neuroimaging Initiative (ADNI1) and ADNI-GO (Grand Opportunity; a study…NCT01231971·Birmingham, Alabama and 57 others

TerminatedA Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205The primary objective is to evaluate the safety and tolerability of aducanumab over 100 weeks of treatment after a wash-out period imposed by discontinuation of feeder studies in…NCT04241068·Birmingham, Alabama and 296 others

CompletedEffectiveness of a Safety App to Respond to Dating Violence for College Women and Their FriendsIntimate partner violence (IPV), including violence in dating relationships (dating violence, DV) is a widespread and serious public health problem.NCT02236663·Phoenix, Arizona and 3 others

CompletedEfficacy Study of MPC-7869 to Treat Patients With Alzheimer'sThe purpose of the study is to evaluate the change in cognitive ability and activities of daily living in patients with Alzheimer's disease (AD) as measured by specific…NCT00105547·Alabaster, Alabama and 131 others

RecruitingScreening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease StudiesThis study is a pre-screening process used to assess participants' potential eligibility for Roche interventional Alzheimer's disease studies.NCT07177352·Birmingham, Alabama and 228 others

CompletedA Long-Term Safety Extension of Studies ABE4869g and ABE4955g in Participants With Mild to Moderate Alzheimer's Disease Treated With CrenezumabThis Phase II, open-label extension (OLE), multicenter study will evaluate the long-term safety and tolerability of crenezumab in participants with mild to moderate Alzheimer's…NCT01723826·Phoenix, Arizona and 85 others

CompletedA Study of Crenezumab in Participants With Mild to Moderate Alzheimer DiseaseThis randomized, placebo-controlled, double-blind, parallel-arm study will evaluate the safety and tolerability of at least two dose levels of intravenous (IV) crenezumab in 24-72…NCT02353598·Phoenix, Arizona and 12 others

Terminated12-Month Open-Label Extension Study of Intepirdine (RVT-101) in Subjects With Alzheimer's Disease: MINDSET ExtensionThis 12-month open-label study will provide further information regarding the long-term safety and tolerability of intepirdine (RVT-101) for subjects with Alzheimer's disease who…NCT02586909·Phoenix, Arizona and 168 others

TerminatedDown Syndrome Clinical Trials - Study of Alzheimer's Disease in Down SyndromeThe primary objective is to characterize trajectories of change on the primary outcome measures in this study population through longitudinal collection of measures of cognition…NCT04149197·Phoenix, Arizona and 13 others

CompletedAC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label ExtThis study will evaluate the effects of daily dosing of AC-1204 on cognition, activities of daily living, resource utilization, quality of life, pharmacokinetic measures and…NCT01741194·Birmingham, Alabama and 81 others

RecruitingA SMART Trial of Adaptive Exercises to Optimize Aerobic-Fitness ResponsesThe goal of this clinical trial is to test 6 months of aerobic exercise in older adults who are 65 years or older and have mild cognitive impairment (MCI) or probable/possible…NCT05877196·Phoenix, Arizona

CompletedA Study of LY3303560 in Participants With Early Symptomatic Alzheimer's DiseaseThe purpose of this study is to evaluate the safety and efficacy of a study drug that targets an abnormal protein in the brain found in people with Alzheimer's Disease (AD).NCT03518073·Phoenix, Arizona and 59 others

PreviousPage 11 of 12Next

Other Conditions in Phoenix

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia